Clinical Trial Update: Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed how telbivudine and tenofovir disoproxil fumarate affect the kinetics of hepatitis B virus DNA in adults with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Telbivudine (telbivudine)

Snippet

Sponsor: The University of Hong Kong | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED